Clinical Trial Record

Return to Clinical Trials

Registry of Pancreatic Disease


2016-12-01


2046-12-01


2046-12-01


3000

Study Overview

Registry of Pancreatic Disease

This clinical data registry records information about the health status and healthcare performances received by participants affected by every type of pancreatic disease or disorder. All data (demographic, clinical, biochemical, radiological, pharmacological, genetic...) and audio and/or video recording from operative room are collected in order to be used for prospective or retrospective studies.

N/A

  • Pancreatic Diseases
  • Pancreatic Neoplasms
  • Pancreatitis
    • PAD-R 1101CESC

    Study Record Dates

    These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

    Study Registration Dates Results Reporting Dates Study Record Updates

    2019-01-15  

    N/A  

    2019-01-15  

    2019-01-15  

    N/A  

    2019-01-17  

    2019-01-17  

    N/A  

    2019-01  

    Study Plan

    This section provides details of the study plan, including how the study is designed and what the study is measuring.

    Design Details

    Primary Purpose:
    N/A


    Allocation:
    N/A


    Interventional Model:
    N/A


    Masking:
    N/A


    Arms and Interventions

    Participant Group/ArmIntervention/Treatment
    : Patient with pancreatic disease

    Patients diagnosed with pancreatic disease evaluated at this institution.

    Primary Outcome MeasuresMeasure DescriptionTime Frame
    Overall survivalSurvival from Diagnosis to time of death1 year
    Secondary Outcome MeasuresMeasure DescriptionTime Frame
    Postoperative morbidityOccurrence of Pancreatic Fistula, Biliary fistula, Enteric fistula, Delayed Gastric Emptying, Hemorrhage or Sepsis.90 days

    Contacts and Locations

    This section provides the contact details for those conducting the study, and information on where this study is being conducted.

    Study Contact

    Name: Erica Secchettin

    Phone Number: +390458126254

    Email: erica.secchettin@aovr.veneto.it

    Participation Criteria

    Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

    Ages Eligible for Study:
    ALL

    Sexes Eligible for Study:
    18 Years

    Accepts Healthy Volunteers:

      Inclusion Criteria:

    • any type of pancreatic disease: inflammatory and neoplastic (including solid and cystic lesions)

    • Exclusion Criteria:

    • physically or mentally inability to provide consent

    Collaborators and Investigators

    This is where you will find people and organizations involved with this study.


      • PRINCIPAL_INVESTIGATOR: Claudio Bassi, Prof, AOUI Verona

      Publications

      The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

      General Publications

      No publications available